ADVERTISEMENT

Crime

Ousted CytoDyn CEO Pourhassan Sentenced To 30 Months For Securities Fraud

The CytoDyn board of directors fired Nader Pourhassan in early 2022 as the company faced US FDA scrutiny over his comments about HIV and COVID-19 candidate leronlimab and as investors sued the firm.

California Firm’s ‘Diverted’ Packaging Used For Dietary Supplements Spiked With ED Drug

“Company employee diverted legitimate packaging and customer information to distribute counterfeit, adulterated product,” says Green Lumber. It’s “working cooperatively with FDA and law enforcement to address this matter.”